Pan-Cancer Markers

Atlas Antibodies

Pan-Cancer Markers for Proteomic Phenotyping

Cancer biomarkers serve as crucial indicators of presence, progression, and characteristics of cancer, and provide valuable diagnostic and prognostic information. While some biomarkers are specific to certain cancer types or tissues, others exhibit pan-cancer characteristics, offering insights into shared molecular features across diverse malignancies.

Pan-cancer markers contribute to the development of universal diagnostic strategies, allowing for the identification of common genetic mutations across diverse cancers, such as the detection of shared pathways implicated in tumorigenesis.

Our partner Atlas Antibodies offers over 300 primary antibodies for such pan-cancer markers, validated on human cancer tissue and cells, to support proteomic studies, complementing genomics, and unveiling additional insights into pathways and processes driving human cancer biology. With validation on 20 human cancers and numerous cancer cell lines (data available on the Human Protein Atlas portal), Atlas' primary antibodies offer comprehensive coverage and enhanced validation for reliable results. Their versatility extends to multiple applications, ensuring they meet the diverse needs of your research projects.